4.3 Article

Metformin Suppresses Hepatocellular Carcinoma through Regulating Alternative Splicing of LGR4

Related references

Note: Only part of the references are listed.
Article Cell Biology

Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity

Li-Hua Lyu et al.

Summary: Accumulating evidence suggests that Circ_0003945, a circRNA, is upregulated in hepatocellular carcinoma (HCC) and is positively correlated with tumor size and stage. Functional experiments show that Circ_0003945 promotes tumor growth and migration. Mechanistically, Circ_0003945 may act as a miR-34c-5p sponge to upregulate LGR4 expression and activate the β-catenin pathway.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)

Article Biochemistry & Molecular Biology

Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol

Fabrizio Fontana et al.

Summary: This study demonstrates the inhibitory effects of delta-TT on glycolytic reprogramming in prostate cancer cells through downregulation of HK2 expression. Additionally, it shows that delta-TT can synergize with metformin to induce cell death, highlighting the importance of metabolic phenotype in delta-TT-mediated cytotoxicity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Gastroenterology & Hepatology

Changing epidemiology of hepatocellular carcinoma in Asia

Chen-hao Zhang et al.

Summary: Liver cancer is a major disease burden in Asia, with hepatocellular carcinoma being the most common type. Hepatitis B and C viruses remain the leading risk factors for HCC, although there has been a slight decline in most Asian countries. However, HCC caused by metabolic factors is increasing rapidly in Asia.

LIVER INTERNATIONAL (2022)

Article Biochemistry & Molecular Biology

Alternative splicing diversifies the transcriptome and proteome of the rice blast fungus during host infection

Jongbum Jeon et al.

Summary: The study reveals that alternative splicing (AS) increases in the rice blast fungus Magnaporthe oryzae during infection process, and identifies dominant isoforms that potentially encode regulatory proteins, suggesting the potential role of AS in regulating rice infection.

RNA BIOLOGY (2022)

Article Oncology

RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma

Yejun Qiao et al.

Summary: Alternative splicing is an important process in cancer that contributes to RNA complexity and protein diversity. This study reveals the potential roles of alternatively spliced genes in hepatocellular carcinoma (HCC), particularly the involvement of the RALY-SF3B3/ MTA1/cholesterol synthesis pathway in HCC development. It suggests that targeting this pathway could be a promising therapeutic strategy for HCC.

CANCER LETTERS (2022)

Article Oncology

LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis

Qi Cheng et al.

Summary: Cancer stem cells (CSCs) are a subpopulation of cancer cells that drive tumor progression and metastasis. This study reports the cooperative role of LGR4 with CD44 and PrPc in defining the stemness characteristics and metastatic capacity of colorectal CSCs. Targeting LGR4 and PrPc with lentiviral shRNAs inhibits tumor growth by inhibiting Wnt/beta-catenin signaling.

CANCER LETTERS (2022)

Article Biotechnology & Applied Microbiology

Metformin Can Enhance the Inhibitory Effect of Olaparib in Bladder Cancer Cells

Bao-Jin Chi et al.

Summary: The combination of metformin and olaparib enhances the anti-tumor effect on bladder cancer cells and regulates the expression of STAT3/C-MYC signaling pathway proteins.

DISEASE MARKERS (2022)

Article Oncology

Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study

Robert P. Carroll et al.

Summary: Maintaining baseline immunosuppression before treatment with an immune checkpoint inhibitor in kidney transplant recipients might not affect expected efficacy and might reduce the risk of allograft rejection mediated by immune checkpoint inhibitors.

LANCET ONCOLOGY (2022)

Article Multidisciplinary Sciences

The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus

Zeinab Tarhini et al.

Summary: The study examined the associations between metformin use and overall survival (OS) and disease-free survival (DFS) in colorectal cancer (CRC) patients with type 2 diabetes mellitus (DM). The findings suggest that metformin use may improve OS and DFS in CRC patients with type 2 DM.

SCIENTIFIC REPORTS (2022)

Article Oncology

PFKFB3 Increases IL-1β and TNF-α in Intestinal Epithelial Cells to Promote Tumorigenesis in Colitis-Associated Colorectal Cancer

Hongbin Yu et al.

Summary: Colorectal cancer (CRC) is closely related to inflammatory bowel disease, and overexpression of PFKFB3 can promote tumorigenesis in colitis-associated CRC (CAC) by inducing phospho-p65 and the expression of IL-1 beta and TNF-alpha, affecting the proliferation, migration, and invasion of cancer cells.

JOURNAL OF ONCOLOGY (2022)

Article Biotechnology & Applied Microbiology

Metformin Can Enhance the Inhibitory Effect of Olaparib in Bladder Cancer Cells

Bao-Jin Chi et al.

Summary: The study demonstrated that metformin could significantly enhance the antitumor effect of olaparib on bladder cancer cells by regulating the expression of STAT3/C-MYC signaling pathway proteins. This finding may have potential clinical implications for the treatment of bladder cancer.

DISEASE MARKERS (2022)

Article Cell Biology

Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation

Hong-Yue Lai et al.

Summary: Activation of autophagy can both promote survival of residual cancer cells and lead to cell death, with implications for sorafenib resistance in hepatocellular carcinoma patients. High EGFR expression is linked to HBV-induced sorafenib resistance, with AMPK/CEBPD-activated autophagy presenting a potential strategy for enhancing sorafenib efficacy.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

The Role of LGR4 (GPR48) in Normal and Cancer Processes

Alejandro Ordaz-Ramos et al.

Summary: LGR4 is a G protein-coupled receptor that regulates cell proliferation, survival, and differentiation through the Wnt/β-catenin pathway in both normal and pathological processes. In cancer, LGR4 plays a role in tumor progression, invasion, and metastasis, and is crucial for regulating cancer stem cell population.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Endocrinology & Metabolism

Lgr4 promotes aerobic glycolysis and differentiation in osteoblasts via the canonical Wnt/β-catenin pathway

Yu-ying Yang et al.

Summary: The lack of Lgr4 results in decreased osteoblast metabolism and bone formation, which can be rescued by activating the canonical Wnt/beta-catenin signaling pathway. Additionally, impaired glycolysis in osteoblasts is observed in mice lacking Lgr4, leading to decreased bone mass and strength.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Article Gastroenterology & Hepatology

Metformin suppresses interleukin-22 induced hepatocellular carcinoma by upregulating Hippo signaling pathway

Dong Zhao et al.

Summary: The study shows that metformin inhibits HCC progression by activating the Hippo signaling pathway and regulating IL-22, thereby reducing the incidence and tumor burden of hepatocellular carcinoma.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Exploring liver cancer biology through functional genetic screens

Cun Wang et al.

Summary: Functional genetic screens play a crucial role in uncovering new genes, identifying therapeutic targets, and guiding the development of new therapeutic strategies in liver cancer biology.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)